Legislation: batch D — NY OH OK OR PA RI SC SD TX UT

Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>

legislation/us/states/ny/2021-2022/a-273.md

@@ -0,0 +1,70 @@
+---
+type: "Bill"
+title: "Relates to consideration and prescription of non-opioid treatment alternatives for treatment of neuromusculoskeletal conditions"
+description: "Requires a practitioner to consider and prescribe non-opioid treatment alternatives for treatment of neuromusculoskeletal conditions."
+jurisdiction: "us/states/ny"
+legislature: "New York Legislature"
+session: "2021-2022"
+identifier: "A 273"
+citation: "New York A 273 (2021-2022)"
+classification: ["bill"]
+subjects: []
+status: "enacted"
+primary_sponsors: ["GOTTFRIED"]
+version_count: 1
+action_count: 13
+vote_count: 2
+first_action: "2021-01-06"
+last_action: "2022-12-23"
+source: "openstates"
+source_identifier: "ocd-bill/83be47cf-c7c2-4008-a836-b6ae70445966"
+source_url: "http://www.nysenate.gov/legislation/bills/2021/A273"
+source_hash: "558c35a002db994c323d8ac9b136f7ee882e3955690237b4e4da4e18458e8f05"
+vintage: "2026-07-01"
+source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
+retrieved_at: "2026-07-06"
+confidence: "reported"
+tags: ["legislation", "bill", "us-ny"]
+---
+
+# New York A 273 (2021-2022) — Relates to consideration and prescription of non-opioid treatment alternatives for treatment of neuromusculoskeletal conditions
+
+Requires a practitioner to consider and prescribe non-opioid treatment alternatives for treatment of neuromusculoskeletal conditions.
+
+## Version chain
+
+The bill's text revisions, in order — the diff chain from filing to enrollment.
+
+1. **A273** (committee substitute) — [source](http://assembly.state.ny.us/leg/?sh=printbill&bn=A273&term=2021&Text=Y)
+
+## Votes
+
+- Assembly Vote — **144–1** (pass) · lower
+- Floor Vote — **60–1** (pass) · upper
+
+## Sponsors
+
+- GOTTFRIED — primary (person)
+
+## Timeline
+
+The legislative action history — every referral, reading, and vote.
+
+- **2021-01-06** REFERRED TO HEALTH `referral-committee`
+- **2021-02-09** REPORTED
+- **2021-02-11** ADVANCED TO THIRD READING CAL.91
+- **2022-01-05** ORDERED TO THIRD READING CAL.19
+- **2022-05-16** PASSED ASSEMBLY `passage`
+- **2022-05-16** DELIVERED TO SENATE
+- **2022-05-16** REFERRED TO HEALTH `referral-committee`
+- **2022-05-25** SUBSTITUTED FOR S4640
+- **2022-05-25** 3RD READING CAL.1332
+- **2022-05-25** PASSED SENATE `passage`
+- **2022-05-25** RETURNED TO ASSEMBLY
+- **2022-12-16** DELIVERED TO GOVERNOR `executive-receipt`
+- **2022-12-23** SIGNED CHAP.732 `executive-signature`
+
+## Source
+
+OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/83be47cf-c7c2-4008-a836-b6ae70445966`. Confidence: reported (aggregated from official New York legislature records).
+